ZENAS BIOPHARMA INC (ZBIO:NASDAQ)

$17.13 -1.04 (-5.7237%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 69

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ZENAS BIOPHARMA INC (ZBIO:NASDAQ) News Sources

IgG4-Related Disease Market Analysis and Forecasts, 2025-2026 & 2035 with Amgen, Zenas BioPharma, Bristol Myers Squibb, and Sanofi Leading

07-05-2026

yahoo.com

Zenas BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Update

13-05-2026

yahoo.com

Zenas BioPharma Announces First Subject Dosed in Phase 1 Clinical Trial of ZB021, a Novel, Potentially Best-in-Class Oral IL-17AA/AF Inhibitor

13-05-2026

yahoo.com

Why Zenas BioPharma (ZBIO) Is Down 7.7% After Reporting a Sharply Wider Quarterly Net Loss

13-05-2026

yahoo.com

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

18-05-2026

yahoo.com

Zenas BioPharma Announces Upcoming Presentation of Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD) at EULAR 2026 Congress

19-05-2026

yahoo.com

Insiders Buy the Dip in These 2 Crushed Stocks With Strong Buy Ratings

21-05-2026

yahoo.com

Zenas BioPharma Announces Submission of Biologics License Application (BLA) to U.S. FDA for Obexelimab in IgG4-RD

28-05-2026

yahoo.com

A Look At Zenas BioPharma (ZBIO) Valuation After Strong 1-Year Return And Recent Share Price Weakness

01-06-2026

yahoo.com

Zenas BioPharma Announces Data from the Registrational Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD), Simultaneously Presented at the EULAR 2026 Congress and Published in the New England Journal of Medicine

02-06-2026

yahoo.com

ZENAS BIOPHARMA INC (ZBIO:NASDAQ) Sentiment Trend

0 25 50 75 100 84 71 81 7 80 73 89 79 63 66 07-05-2026 13-05-2026 18-05-2026 19-05-2026 21-05-2026 28-05-2026 01-06-2026 02-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ZENAS BIOPHARMA INC (ZBIO:NASDAQ) FAQs

toggle

What is the current price of ZENAS BIOPHARMA INC (ZBIO:NASDAQ)?

The current price of ZENAS BIOPHARMA INC (ZBIO:NASDAQ) is $17.13.


toggle

ZENAS BIOPHARMA INC (ZBIO:NASDAQ) absolute price change since previous trading day?

The absolute price change of ZENAS BIOPHARMA INC (ZBIO:NASDAQ) since the previous trading day is $-1.04.


toggle

ZENAS BIOPHARMA INC (ZBIO:NASDAQ) percentage price change since previous trading day?

The percentage price change of ZENAS BIOPHARMA INC (ZBIO:NASDAQ) since the previous trading day is -5.7237%.


toggle

What is the most recent average sentiment score for ZENAS BIOPHARMA INC (ZBIO:NASDAQ)?

The most recent average sentiment score for ZENAS BIOPHARMA INC (ZBIO:NASDAQ) is 69 out of 100.


toggle

What is the most recent average sentiment for ZENAS BIOPHARMA INC (ZBIO:NASDAQ)?

The most recent sentiment for ZENAS BIOPHARMA INC (ZBIO:NASDAQ) is .


SEC-8K** Filing Available For ZENAS BIOPHARMA INC (ZBIO:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.